Amphiregulin as a biomarker for monitoring lifethreatening acute graft-<i>versus</i>-host disease: secondary analysis of two prospective clinical trials

Slični predmeti

• Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802
  od: Shernan G. Holtan, i dr.
  Izdano: (2018-08-01)
• Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults
  od: Rohtesh S. Mehta, i dr.
  Izdano: (2016-06-01)
• Amphiregulin as a biomarker for monitoring lifethreatening acute graft-<i>versus</i>-host disease: secondary analysis of two prospective clinical trials
  od: Shernan G. Holtan, i dr.
  Izdano: (2023-09-01)
• Antibiotic risk score for acute graft-versus-host disease
  od: Armin Rashidi, i dr.
  Izdano: (2026-02-01)
• Life-Threatening Hypertriglyceridemia in a Patient on Ruxolitinib and Sirolimus for Chronic Graft-versus-Host Disease
  od: Allison P. Watson, i dr.
  Izdano: (2018-01-01)